Search

Your search keyword '"Gram, Inger T."' showing total 539 results

Search Constraints

Start Over You searched for: Author "Gram, Inger T." Remove constraint Author: "Gram, Inger T."
539 results on '"Gram, Inger T."'

Search Results

101. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension: a population-based intervention trial from the Tromso Study

102. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium

105. Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium

106. Breast Cancer Risk After Recent Childbirth

107. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density

108. Tumor-associated autoantibodies as early detection markers for ovarian cancer? : A prospective evaluation

109. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

110. Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk : Results from the EPIC Cohort

111. Anti-CA15.3 and anti-CA125 antibodies and ovarian cancer risk : Results from the EPIC cohort

112. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

113. Anti-CA15.3 and anti-CA125 antibodies and ovarian cancer risk: Results from the EPIC cohort

114. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

115. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort

117. Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

118. Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort

119. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

121. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies.

122. The Premenopausal Breast Cancer Collaboration : A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.

123. The premenopausal breast cancer collaboration : A pooling project of studies participating in the national cancer institute cohort consortium

124. The premenopausal breast cancer collaboration: A pooling project of studies participating in the national cancer institute cohort consortium

125. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort

126. An epidemiological model for prediction of endometrial cancer risk in Europe

127. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

128. Combined effects of smoking and HPV16 in oropharyngeal cancer

130. The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

132. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies

133. Investigation of Dietary Factors and Endometrial Cancer Risk Using a Nutrient-wide Association Study Approach in the EPIC and Nurses' Health Study (NHS) and NHSII

134. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition

135. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort

136. Ovarian Cancer Risk Factors by Histologic Subtype : An Analysis From the Ovarian Cancer Cohort Consortium

137. Combined effects of smoking and HPV16 in oropharyngeal cancer

138. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer : Results from the EPIC Cohort

139. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

140. Combined effects of smoking and HPV16 in oropharyngeal cancer

141. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

142. An epidemiological model for prediction of endometrial cancer risk in Europe

143. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: Evidence from the EPIC cohort

144. Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort

145. Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohort

146. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

149. Combined effects of smoking and HPV16 in oropharyngeal cancer

150. Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

Catalog

Books, media, physical & digital resources